MYROVLYTIS TRUST

Registered charity 1122073 · accounts filings on the Charity Commission register · also known as MYROVLYTIS TRUST LIMITED · filing overdue (register status)

Promote research into rare disorders and advance education of the public in medical and molecular genetics.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · Get email alerts

Latest income
£594k
Latest spending
£900k
Registered
2007
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that the charity's unrestricted funds have decreased to a deficit of £297,005 as of March 2024, following significant grant funding expenditures. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future and have adopted the going concern basis. The charity operates a defined contribution pension scheme and has no disclosed trading subsidiaries.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: three to six months of operational costs (held: £-297k)
“The Trustees aim to maintain free reserves in unrestricted funds at a level which equates to approximately three to six months of operational costs.” — page 9
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Insolvency history (Companies House)

The charity’s company has insolvency history on the Companies House record (company status: liquidation).
creditors-voluntary-liquidation — 2025-07-23
Official Companies House insolvency record. Insolvency of a subsidiary does not mean the charity is insolvent.

Corporate structure

Public fundraising profile: JustGiving — Myrovlytis Trust (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Structured financials (annual return, FY ending 31/03/2024)

Total income
£594k
Total spending
£900k
Reserves (reported)
£0
Employees
4

Reported reserves equal ~0.0 months of spending — in the bottom quarter for charities its size (median 5.2 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (99% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (4.9%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Argentina · Australia · Austria · Bangladesh · Belgium · Bolivia · Brazil · Canada · China · Croatia · Denmark · Finland

Income and spending

Financial year endIncomeSpending
31/03/2025——
31/03/2024£594k£900k
30/09/2022£342k£332k
30/09/2021£159k£145k
30/09/2020£323k£348k

Common questions

Is MYROVLYTIS TRUST financially healthy?

Per its FY2024 accounts: The accounts state that the charity's unrestricted funds have decreased to a deficit of £297,005 as of March 2024, following significant grant funding expenditures. The trustees report that the charity has adequate resources to continue in operational existence for the foreseeable future and have adopted the going concern basis. The charity operates a defined contribution pension scheme and has no disclosed trading subsidiaries. Its FY2024 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with MYOTUBULAR TRUST.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
MYROVLYTIS TRUST£594k—0unclear—no doubt
MYOTUBULAR TRUST FY2025£147k£20,0000unclear—no doubt
MY MITO MISSION FY2024£132k—0unclear—no doubt
MYRISTICA TRUST FY2025£4.1m—0unclear—no doubt
MYOSITIS UK FY2025£140k—0unclear—no doubt
MYR CHARITABLE TRUST FY2024£114k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.